Nexalin Technology (NXL) Change in Acquisitions & Divestments (2023 - 2026)
Nexalin Technology (NXL) posted Change in Acquisitions & Divestments of $5.6 million for Q1 2026, down 41.03% on a QoQ basis from $9.5 million in Q4 2025, and down 13.95% year-over-year from $6.5 million in Q1 2025.
Analysis
Nexalin Technology (NXL) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Nexalin Technology has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $5.6 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 13.95% year-over-year to $5.6 million in Q1 2026; TTM through Mar 2026 was $39.8 million, a 18.91% increase from a year earlier, with the FY2025 full-year figure at $40.7 million, up 22.58% from the prior year.
- Change in Acquisitions & Divestments was $5.6 million for Q1 2026 at Nexalin Technology, down from $9.5 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $13.5 million in Q3 2025, with the low at $2.9 million in Q2 2024.
- Average Change in Acquisitions & Divestments over 4 years is $9.3 million, with a median of $9.6 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments sank 69.29% in 2024, then surged 281.83% in 2025.
- Over 4 years, Change in Acquisitions & Divestments stood at $8.6 million in 2023, then advanced by 26.36% to $10.9 million in 2024, then fell by 12.85% to $9.5 million in 2025, then sank by 41.03% to $5.6 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $5.6 million (Q1 2026), $9.5 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.59 Mn |
| Dec 31, 2025 | 9.48 Mn |
| Sep 30, 2025 | 13.55 Mn |
| Jun 30, 2025 | 11.21 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 10.88 Mn |
| Sep 30, 2024 | 13.18 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Mar 31, 2024 | 6.24 Mn |
| Dec 31, 2023 | 8.61 Mn |
| Sep 30, 2023 | 11.52 Mn |
| Jun 30, 2023 | 9.56 Mn |
| Mar 31, 2023 | 11.60 Mn |